
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Butterfly Network Inc (BFLY)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: BFLY (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -42.25% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 575.73M USD | Price to earnings Ratio - | 1Y Target Price 5 |
Price to earnings Ratio - | 1Y Target Price 5 | ||
Volume (30-day avg) 3946823 | Beta 2.49 | 52 Weeks Range 0.67 - 4.98 | Updated Date 04/1/2025 |
52 Weeks Range 0.67 - 4.98 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -88.35% | Operating Margin (TTM) -75.55% |
Management Effectiveness
Return on Assets (TTM) -15.69% | Return on Equity (TTM) -37.28% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 487924783 | Price to Sales(TTM) 7.02 |
Enterprise Value 487924783 | Price to Sales(TTM) 7.02 | ||
Enterprise Value to Revenue 5.95 | Enterprise Value to EBITDA -9.57 | Shares Outstanding 216496000 | Shares Floating 184152753 |
Shares Outstanding 216496000 | Shares Floating 184152753 | ||
Percent Insiders 14.88 | Percent Institutions 29.79 |
Analyst Ratings
Rating 5 | Target Price 4.42 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Butterfly Network Inc
Company Overview
History and Background
Butterfly Network, Inc. was founded in 2011 by Jonathan Rothberg. It aimed to democratize medical imaging by developing a single-probe, whole-body ultrasound device using semiconductor technology. Butterfly went public in 2021 via a SPAC merger with Longview Acquisition Corp.
Core Business Areas
- Point-of-Care Ultrasound (POCUS): The primary focus is the development and commercialization of the Butterfly iQ+, a handheld, whole-body ultrasound imaging device and related software platform.
- Enterprise Solutions: Butterfly provides enterprise-level software and services to hospitals and healthcare systems to manage and optimize their ultrasound imaging workflows.
Leadership and Structure
Dr. Joseph DeVivo is the CEO. The organizational structure is typical of a publicly traded technology company, with departments covering engineering, sales, marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- Butterfly iQ+: A single-probe, whole-body ultrasound imaging device using ultrasound-on-chip technology. While precise market share data is unavailable, Butterfly is a major innovator in point-of-care ultrasound, competing with traditional ultrasound manufacturers like GE Healthcare (GE), Philips (PHG), and Siemens Healthineers (SIEMENS.DE).
- Butterfly Cloud: A software platform for image storage, collaboration, and AI-powered image analysis. Revenue is generated through subscription fees. Competitors include numerous PACS and medical imaging software providers. No explicit Market Share data is provided from Butterfly.
Market Dynamics
Industry Overview
The medical imaging industry is large and growing, driven by aging populations, chronic diseases, and technological advancements. Point-of-care ultrasound is a rapidly expanding segment due to its portability, ease of use, and lower cost compared to traditional ultrasound systems.
Positioning
Butterfly Network is positioned as a disruptor in the ultrasound market, offering a more affordable and accessible alternative to traditional ultrasound systems. Their competitive advantage lies in their innovative ultrasound-on-chip technology and integrated software platform.
Total Addressable Market (TAM)
The Total Addressable Market (TAM) for the global medical imaging market is estimated to be in the tens of billions of dollars annually. Butterfly Network is positioned to capture a portion of this TAM by targeting the point-of-care ultrasound segment. Exact TAM estimations for Point-Of-Care ultrasound varies widely by report.
Upturn SWOT Analysis
Strengths
- Innovative ultrasound-on-chip technology
- Portability and ease of use
- Lower cost compared to traditional ultrasound
- Integrated software platform
- Strong intellectual property portfolio
Weaknesses
- Relatively small market share compared to established players
- Dependence on regulatory approvals
- Negative profit margin
- Need for continuous innovation and product development
- Limited brand recognition compared to competitors
Opportunities
- Expanding point-of-care ultrasound market
- Growing demand for remote patient monitoring
- Increasing adoption of AI in medical imaging
- Partnerships with healthcare providers and technology companies
- Expanding into new geographies and clinical applications
Threats
- Competition from established medical imaging companies
- Technological obsolescence
- Regulatory changes
- Economic downturn
- Reimbursement challenges
Competitors and Market Share
Key Competitors
- GE (GE)
- Philips (PHG)
- Siemens (SIE.DE)
Competitive Landscape
Butterfly Network offers lower cost options while traditional competitors like GE, Siemens, and Philips have economies of scale, longer sales histories and relationships with the larger customers, such as hospitals. Butterfly is more flexible.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Growth has been achieved with the rollout of the iQ+ product line. However, with significant competition, growth has been slow in the latest period.
Future Projections: Future projections depend on analyst estimates and the company's guidance. Usually found through Yahoo Finance or TipRanks.
Recent Initiatives: Recent initiatives include expanding the sales force, developing new clinical applications for the Butterfly iQ+, and partnering with healthcare providers to integrate their technology into clinical workflows.
Summary
Butterfly Network is an innovative company in the point-of-care ultrasound market, offering a more accessible alternative to traditional ultrasound systems. Its strengths lie in its proprietary technology and integrated software platform, but it faces challenges from larger, more established competitors. Future success depends on its ability to continue innovating, expanding its market share, and achieving profitability. The company needs to navigate regulatory hurdles and reimbursement challenges to secure its long-term growth potential.
Similar Companies
- GE
- PHG
- SIEMENS.DE
Sources and Disclaimers
Data Sources:
- Company SEC Filings (e.g., 10-K, 10-Q)
- Company Website
- Third-Party Market Research Reports
- Analyst Reports (e.g., Yahoo Finance, TipRanks)
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Investment decisions should be made based on your own research and due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Butterfly Network Inc
Exchange NYSE | Headquaters Burlington, MA, United States | ||
IPO Launch date 2020-07-13 | CEO, President & Chairman of the Board Mr. Joseph M. DeVivo | ||
Sector Healthcare | Industry Medical Devices | Full time employees 190 | Website https://www.butterflynetwork.com |
Full time employees 190 | Website https://www.butterflynetwork.com |
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly iQ+ Bladder, a specialty product for the bladder scanning market; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. It also provides Butterfly system, which includes probes, related accessories, and software subscriptions to healthcare systems, physicians, and healthcare providers. In addition, the company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments; and ScanLab, an education-only app that provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. It sells its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.